Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (251-260 of 322) with videos related to

Pageof 33
Sort By:
American Journal of Human Genetics|December 12, 2003
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African AmericansJorge R Oksenberg, Lisa F Barcellos, Bruce A C Cree, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.
Human Molecular Genetics|March 10, 2010
CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosisPaola G Bronson, Stacy Caillier, Patricia P Ramsay, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Annals of Neurology|June 3, 2004
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosisLisa F Barcellos, Ann B Begovich, Rebecca L Reynolds, et al.
Annals of Neurology|August 5, 2014
Spinal cord gray matter atrophy correlates with multiple sclerosis disabilityRegina Schlaeger, Nico Papinutto, Valentina Panara, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisStephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalban, Stephen L Hauser, Ludwig Kappos, et al.
Human Molecular Genetics|August 15, 2006
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosisLisa F Barcellos, Stephen Sawcer, Patricia P Ramsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2017
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse modelsEgle Cekanaviciute, Bryan B Yoo, Tessel F Runia, et al.
Pageof 33

Showing results (251-260 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Human Genetics|December 12, 2003
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African AmericansJorge R Oksenberg, Lisa F Barcellos, Bruce A C Cree, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2022
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosisValerie J Block, Shuiting Cheng, Jeremy Juwono, et al.
Human Molecular Genetics|March 10, 2010
CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosisPaola G Bronson, Stacy Caillier, Patricia P Ramsay, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Annals of Neurology|June 3, 2004
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosisLisa F Barcellos, Ann B Begovich, Rebecca L Reynolds, et al.
Annals of Neurology|August 5, 2014
Spinal cord gray matter atrophy correlates with multiple sclerosis disabilityRegina Schlaeger, Nico Papinutto, Valentina Panara, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisStephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalban, Stephen L Hauser, Ludwig Kappos, et al.
Human Molecular Genetics|August 15, 2006
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosisLisa F Barcellos, Stephen Sawcer, Patricia P Ramsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2017
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse modelsEgle Cekanaviciute, Bryan B Yoo, Tessel F Runia, et al.
Pageof 33